Search

Your search keyword '"Bertsias, George"' showing total 848 results

Search Constraints

Start Over You searched for: Author "Bertsias, George" Remove constraint Author: "Bertsias, George"
848 results on '"Bertsias, George"'

Search Results

151. Additional file 1 of Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort

153. Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus : A multi-center observational study

154. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.

156. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

158. Contributors

159. Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

160. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

161. Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort

163. Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study

166. Nutrient intake and food consumption among medical students in Greece assessed during a Clinical Nutrition course

170. List of Contributors

172. Contributors

173. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

174. Contributors

185. Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-years outcome compared to persistent low-remission status and represent a heterogeneous group.

186. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

187. Rheumatoid Arthritis Patients On Persistent Moderate Disease Activity On Biologics Have Adverse 5-years Outcome Compared To Persistent Low-remission Status Yet They Represent A Heterogeneous Group: Lower-moderate Has Better Functionality And Fewer Serious Adverse Events Than Higher-moderate Subgroup

189. Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI)

190. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study

195. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

198. O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease

200. Hydroxychloroquine‐induced erythema multiforme

Catalog

Books, media, physical & digital resources